these things, that drugmaker talking about that pfizer drug. i feel incredibly bullish on the prospects for that drug, just because it s clinical trials data was so impressive. the unanimous recommendation from vaccine advisory group, that it should be approved. the fact that it is easy to administer. three pills twice a day, five days, you re don. such effectiveness. three days after symptoms s, may be hard to do, but still show some effectiveness. people get to five days after symptoms. there s so much good to say this about the pfizer pill, and how many lives it could save. the only part about it is how few doses there are. i know the united states government is buying up everything that we can, are we at the physical, and scientific limit, in terms of what can be produced, in terms of that pfizer drug? i know there s a lot of the merck drug, which has a lot of is a less appealing in a lot of ways. but that pfizer pill is so
changer. just as a lay observer of these things, that drug you re talking about, that pfizer drug, i feel incredibly bullish on the prospects for that drug, just because it is clinical trials data was so impressive that unanimous recommendation from the vaccine advisory group that it should be approved, the fact that it is easy to administer, it is three pills twice a day, five days, boom, you re done, just such effectiveness, three days after symptoms, is, you know, maybe hard to do, still shows some effectiveness and people get it five days after symptoms. there is so much good to say about that pfizer pill and how many lives it could save. the only part about it that i despair of is how few doses there are and i know that the united states government is buying up everything we can there, but is there are we at the physical and scientific limit in terms of when what could be produced in terms of that pfizer drug? there is a lot of the merck drug, which has a lot is less appea